期刊文献+

肥胖对后路腰椎融合术疗效影响的研究进展 被引量:3

Research progress in effect of obesity on the effectiveness of posterior lumbar fusion
原文传递
导出
摘要 目的综述肥胖对腰椎退变性疾病(lumbar degenerative diseases,LDD)患者后路腰椎融合术疗效的影响。方法广泛查阅近年国内外相关文献,总结肥胖LDD患者行后路腰椎融合术治疗的操作难度、并发症发生风险及远期临床疗效。结果虽然有相关文献提示肥胖患者后路腰椎融合术操作难度大,术后并发症发生风险高,但总的研究结果并未提示肥胖是施行后路腰椎融合术式的危险因素。通过评估患者身体状况,严格把握手术指征,肥胖患者能够获得良好手术疗效。结论后路腰椎融合术是治疗肥胖LDD的有效手段,但相关研究仍需完善,以进一步评估肥胖患者后路腰椎融合术的安全性和有效性。 Objective To review the effect of obesity on the effectiveness of posterior lumbar fusion in patients with lumbar degenerative diseases(LDD).Methods The related literature at home and abroad was extensively reviewed.And the difficulty of operation,risk of complications,and long-term effectiveness of posterior lumbar fusion for obese patients with LDD were summarized.Results Although some relevant literature suggest that the posterior lumbar fusion for obese patients is difficult and the risk of postoperative complications is high,the overall research results do not suggest that obesity is a risk factor for the implementation of posterior lumbar fusion.By assessing the physical condition of patients and strictly grasping the surgical indications,obese patients can obtain good surgical efficacy.Conclusion Posterior lumbar fusion is an effective method for the treatment of LDD in obese patients.However,relevant studies need to be completed to further evaluate the safety and efficacy of posterior lumbar fusion for obese patients.
作者 徐玉柱 王运涛 姜峰 张彬 XU Yuzhu;WANG Yuntao;JIANG Feng;ZHANG Bin(Department of Spine Surgery,Zhongda Hospital Affiliated to Southeast University,Nanjing Jiangsu,210009,P.R.China)
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2021年第1期130-136,共7页 Chinese Journal of Reparative and Reconstructive Surgery
基金 国家自然科学基金资助项目(81572109)。
关键词 肥胖 腰椎退变性疾病 后路腰椎融合术 并发症 Obesity lumbar degenerative disease posterior lumbar fusion complication
  • 相关文献

参考文献8

二级参考文献282

  • 1张亚峰,杨惠林,唐天驷,史勇.后路椎体间融合术后融合器脱出的原因及其翻修术[J].中国脊柱脊髓杂志,2006,16(12):909-912. 被引量:25
  • 2American Medical Association. Council on Science and PublicHealth Report, 2013.
  • 3Obesity: preventing and managing the global epidemic. Report of aWHO consultation. World Health Organ Tech Rep Ser 2000; 894:i-xii, 1-253 [PMID: 11234459].
  • 4Nigro E, Scudiero O, Monaco ML, Palmieri A, Mazzarella G,Costagliola C, Bianco A, Daniele A. New insight into adiponectinrole in obesity and obesity-related diseases. Biomed Res Int 2014;2014: 658913 [PMID: 25110685 DOI: 10.1155/2014/658913].
  • 5Recognition of Obesity as a Disease. Available from: URL: http://www.npr.org/documents/2013/jun/ama-resolution-besity.pdf.
  • 6Bray GA, Bellanger T. Epidemiology, trends, and morbidities ofobesity and the metabolic syndrome. Endocrine 2006; 29: 109-117[PMID: 16622298].
  • 7Shuldiner AR. Obesity genes and gene-environment-behaviorinteractions: recommendations for a way forward. Obesity (SilverSpring) 2008; 16 Suppl 3: S79-S81 [PMID: 19037219 DOI:10.1038/oby.2008.523].
  • 8Sesti G, Perego L, Cardellini M, Andreozzi F, Ricasoli C, VedaniP, Guzzi V, Marchi M, Paganelli M, Ferla G, Pontiroli AE, HribalML, Folli F. Impact of common polymorphisms in candidategenes for insulin resistance and obesity on weight loss of morbidlyobese subjects after laparoscopic adjustable gastric banding andhypocaloric diet. J Clin Endocrinol Metab 2005; 90: 5064-5069[PMID: 15985484].
  • 9Hajer GR, van Haeften TW, Visseren FL. Adipose tissuedysfunction in obesity, diabetes, and vascular diseases. Eur HeartJ 2008; 29: 2959-2971 [PMID: 18775919 DOI: 10.1093/eurheartj/ehn387].
  • 10Shah A, Mehta N, Reilly MP. Adipose inflammation, insulinresistance, and cardiovascular disease. JPEN J Parenter EnteralNutr 2008; 32: 638-644 [PMID: 18974244 DOI: 10.1177/0148607108325251].

共引文献50

同被引文献18

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部